INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,187 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$222K
2,912 sh
Nov 19, 2025
Page 1770 of 1855
← PrevNext →
Nov 21, 2025
traded Nov 19, 2025
+2d
SEC Form 4

Evidence

25
EA
Eltoukhy AdamSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$22K
600 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$96K
2,470 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$106K
2,770 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$179K
4,599 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

24
MM
Moran James MVP & Treasurer
DOVDOVER Corp
Option exercise
M$180K
3,729 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

24
YE
Young William ERetired Director
SMBCSOUTHERN MISSOURI BANCORP, INC.
Open-market sale
SELL$81K
1,500 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

24
GM
Gloria MelanieChief Operating Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$57K
2,375 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

23
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
197 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

23
HJ
Holstein JensDirector
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$61K
1,491 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

22
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$8,978
230 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
PG
Poilasne GregoryDirector, Chief Executive Officer
NVVENuvve Holding Corp.
Grant or award
A—
1.32M sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
CA
Christenson AliceChief Accounting Officer
PTCPTC INC.
Grant or award
A—
1,104 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
CD
Cone C. DavidDirector
BROSDutch Bros Inc.
Option exercise
M—
445 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$268K
12.0K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
MJ
McVeety Kristen JGC and Secretary
CRWVCoreWeave, Inc.
Option exercise
M—
4,347 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
MK
Marchisotto KoryDirector
BROSDutch Bros Inc.
Option exercise
M—
445 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
MM
Miller Ann MDirector
BROSDutch Bros Inc.
Option exercise
M—
445 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Open-market sale · 10b5-1 plan
SELL$342K
9,701 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
YS
Yoon SungSVP
KEYSKeysight Technologies, Inc.
Grant or award
A—
6,429 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
RD
Robson DavidChief Financial Officer
NVVENuvve Holding Corp.
Grant or award
A—
1.00M sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
PA
Penegor Todd AllanDirector
BROSDutch Bros Inc.
Option exercise
M—
445 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
SC
Smith Ted C.Director, President and COO
NVVENuvve Holding Corp.
Grant or award
A—
200.0K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
HC
Hanley David C.CHIEF TECHNICAL OPERATIONS
NUVBNuvation Bio Inc.
Option exercise
M—
200.0K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$181K
4,628 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
PG
Poilasne GregoryDirector, Chief Executive Officer
NVVENuvve Holding Corp.
Grant or award
A—
2.00M sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
GS
Gillett StephenDirector
BROSDutch Bros Inc.
Option exercise
M—
445 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
MK
Marchisotto KoryDirector
BROSDutch Bros Inc.
Option exercise
M—
445 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
HJ
Hart Gerard JohanDirector
BROSDutch Bros Inc.
Option exercise
M—
445 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
DJ
Davis Thomas JamesDirector
BROSDutch Bros Inc.
Option exercise
M—
445 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
HR
Horn David R.PRESIDENT & CFO
SEERSeer, Inc.
Open-market sale
SELL$13K
6,797 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
GK
George KathrynDirector
BROSDutch Bros Inc.
Option exercise
M—
445 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
RD
Robson DavidChief Financial Officer
NVVENuvve Holding Corp.
Grant or award
A—
937.1K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

20
WB
Wilms BrettPresident - EMEA & Australia
BRCBRADY CORP
Option exercise
M$163K
3,266 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

20
NS
Newcomb Matthew SChief Financial Officer
CHYMChime Financial, Inc.
Gift
G—
102.9K sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

20
WB
Wilms BrettPresident - EMEA & Australia
BRCBRADY CORP
Option exercise
M$156K
2,882 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

20
WB
Wilms BrettPresident - EMEA & Australia
BRCBRADY CORP
Option exercise
M$142K
3,563 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

19
NK
Narayanan KailashSVP
KEYSKeysight Technologies, Inc.
Tax withholding
F$314K
1,798 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

19
LP
Liberman PaulDirector, See Remarks
DKNGDraftKings Inc.
Option exercise
M$293K
89.2K sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

19
MG
Mcdonough GeoffDirector
GBIOGeneration Bio Co.
Option exercise
M—
659 sh
Oct 31, 2025Nov 21, 2025
traded Oct 31, 2025
+21dSEC Form 4

Evidence